Cornea/External Disease News

CHICAGO — In this Healio Video Perspective from the AAO meeting, Guillermo Amescua, MD, discusses his experience using ImprimisRx’s Fortisite, a compounded combination of tobramycin 1.5% and vancomycin 5%.

The phase 2b/3 OASIS-1 trial of ALY688 ophthalmic solution for the treatment of dry eye disease has completed patient enrollment, according to a press release from Allysta Pharmaceuticals.

Children who are more physically fit than their peers experience reduced risk for allergic conjunctivitis, according to a study presented at American Academy of Ophthalmology 2022.

MONTEREY, Calif. — There is more than one way to treat neurotrophic keratopathy.

MILAN — At the ESCRS meeting, Farhad Hafezi, MD, PhD, speaks about a newly developed algorithm for cross-linking in thin corneas.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Christopher E. Starr, MD, discusses post hoc data investigating Tyrvaya nasal spray for dry eye disease treatment in patients on antidepressants.

MILAN — At the ESCRS meeting, Efekan Çoşkunseven, MD, speaks about combined treatment in keratoconus.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Francis W. Price Jr., MD, discusses an engineered fibroblast growth factor from Trefoil Therapeutics for Fuchs’ endothelial corneal dystrophy.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Gustavo De Moraes, MD, PhD, MPH, of Ora, discusses the Ora EyeCup, a new imaging device that monitors eye redness and irritation.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Michelle Senchyna, PhD, of Aerie Pharmaceuticals, provides an update on the company’s ongoing projects.